Background
==========

The final stage of bovine follicular development occurs in a wave-like fashion \[[@B1],[@B2]\]. During a wave, increase of follicle-stimulating hormone (FSH) induces recruitment of a cohort of follicles beyond 4 mm in diameter and usually a single follicle is selected as a dominant follicle (DF) \[[@B3],[@B4]\]. Although the DF continues to grow by transition of gonadotropin dependency from FSH to luteinizing hormone (LH) and secretes large quantities of estradiol (E~2~), the remaining subordinate follicles (SFs) cease to grow, then undergo atresia \[[@B5]\]. It is well documented that increased expression of LH receptor (LHR) in granulosa cells (GC) and specific changes of intrafollicular factors such as the insulin-like growth factor (IGF) and inhibin-activin-follistatin systems play a critical role in E~2~production in the DF \[[@B6],[@B7]\]. Therefore, regulatory mechanisms of follicular development are closely associated with complex interactions between follicular local paracrine/autocrine factors and endocrine hormones.

Increasing evidence using global gene expression analysis such as a DNA microarray, suppression subtractive hybridization and serial analysis of gene expression have identified numerous genes in various aspects of bovine follicular development \[[@B8]-[@B18]\]. Some studies compared the gene expression profiles between DF and SF around the time of follicular selection. They showed that DF up-regulates genes regulating E~2~synthesis, anti-apoptosis, cell proliferation and gene transcription. Conversely, SF enhanced the expression of genes associated with pro-apoptosis and cell death compared with the DF \[[@B8],[@B9],[@B13],[@B14]\]. Recent studies found that 93 mostly novel genes were differently expressed in the GC of newly selected DF compared with SF and/or growing cohort follicles whereas most of these genes were down-regulated in the GC of preovulatory follicles during final maturation before the LH surge \[[@B15],[@B17]\]. Growth of a DF during 2-5.5 days following follicular wave emergence was associated with a decrease in genes encoding proliferation and pro-apoptotic factors and an increase in genes regulating anti-apoptotic factors \[[@B12]\]. An increase in follicular diameter during follicular growth was accompanied by alteration of gene expression regulating some growth factors and cytokines \[[@B16],[@B18]\]. Ndiaye *et al*. identified a subset of novel genes down-regulated in preovulatory follicles after human chorionic gonadotropin (hCG) stimulation compared with DF, which may contribute to ovulation and luteinization \[[@B11]\].

These previous studies lead us to suggest that gene expression profiles in individual follicles reflect their developmental status, thus each follicle can be classified by differences in gene expression profiles. On the other hand, details of the genetic processes and biological pathways regulating bovine follicular development still remain to be elucidated. We consider that investigating the global gene expression of follicles after selection can help to understand the molecular mechanisms responsible for the regulation and control of follicular development and atresia. Therefore, in this study, we tried to classify the largest (F1) and second-largest (F2) follicles according to differences in gene expression profiles and to identify differentially expressed genes between the groups using a combination of microarray analysis and quantitative real-time PCR (QPCR) analysis. In addition, spatial expression profiles of several identified genes were investigated using *in situ*hybridization in healthy and atretic follicles classified based on follicular fluid (FF) concentration of steroids.

Methods
=======

Experiment 1: classification of F1 and F2 and identification of genes by microarray analysis and QPCR analysis
--------------------------------------------------------------------------------------------------------------

### Sample collection and RNA extraction

Paired ovaries were obtained from four pregnant Japanese Black cows in the institute ranch less than 10 min after slaughtering. These cows were pregnant and slaughtered for another study. Both F1 and F2 were dissected from the ovaries. Then, the surrounding stroma and theca externa were removed from the follicular walls. We collected three F1 and three F2 from four cows because two cows had both F1 and F2 collected whereas one cow had only a F1 collected and another cow had only a F2 collected. The follicles were snap-frozen and stored at -80°C until RNA extraction. Total RNA from the follicular wall (i.e., granulosa plus theca interna) was extracted from each follicle using ISOGEN (NipponGene, Tokyo, Japan) according to the manufacturer\'s instructions. All procedures for animal experiments were carried out in accordance with guidelines approved by the Animal Ethics Committee of the National Institute of Agrobiological Sciences for the use of animals.

### Microarray analysis

A custom-made bovine oligonucleotide microarray fabricated by Agilent Technologies (Santa Clara, CA, USA) was used in this study. Sixty-mer nucleotide probes for customized microarray were synthesized on a glass slide. The annotated bovine oligonucleotide array represented 10263 sequences 4466 of which were known bovine genes, 5697 were unknown sequences and possible candidates for novel bovine genes, and 100 internal references.

We performed one-color microarray using five follicles (three F1 and two F2). Fluorescence-labeled (Cy3) cRNA probes were prepared from 150-300 ng of total RNA of each follicle using a Low RNA Input Linear Amplification Kit (Agilent Technologies). Labeled cRNA probes (750 ng each) were hybridized to the customized microarray in hybridization buffer (Gene Expression Hybridization Kit, Agilent Technologies) at 60°C for 17 h. After hybridization, the arrays were washed with 6 × SSC, 0.005% Triton X-102 at room temperature for 10 min, followed by 5-min washes in 0.1 × SSC, 0.005% Triton X-102 at 4°C. Hybridized arrays were blow dried with N~2~gas and scanned using an Agilent Microarray Scanner (Agilent Technologies), and Feature Extraction ver. 9.1 (Agilent Technologies) was used for image analysis and data extraction. Gene expression datasets were normalized using the median of the signal intensity for 100 *GAPDH*genes on a microarray platform as internal control.

After normalization, 3308 genes were left to use for further analysis. The relative abundance of individual genes between follicles was calculated by dividing the normalized value of the genes between each follicle. We used the normalized microarray data of genes that showed an expression level of more than 20-fold between at least two follicles for subsequent hierarchical cluster analysis. The data were transformed log~2~values and hierarchical cluster analysis was performed using the TIGR MultiExperiment Viewer 4.0 (MeV 4.0) software program \[[@B19]\]. Two parameters (average linkage and cosine correlation) were selected for constructing the hierarchical tree. Compliance with Minimum Information About a Microarray Experiment (MIAME) \[[@B20]\] was assured by depositing all the data in the Gene Expression Omnibus (GEO) repository \[[@B21]\]. The GEO accession numbers are as follows. Platform: GPL9136; Samples: GSM453634, GSM453635, GSM453636, GSM453637 and GSM453638; Series: GSE18145.

### Quantitative real-time RT-PCR analysis

To validate the results of microarray analysis, we confirmed mRNA expression of 16 representative genes using QPCR analysis. All six follicles were used in QPCR analysis. The procedures for QPCR were previously described \[[@B22]\]. Briefly, single-strand cDNA was reverse-transcribed from 50 ng of total RNA using MultiScribe™ reverse transcriptase with a random primer, dNTP mixture, MgCl~2~and RNase inhibitor (Applied Biosystems, Foster City, CA, USA). The reverse transcription cycle consisted of 10 min annealing at 25°C, 30 min cDNA synthesis at 48°C and 5 min inactivation at 95°C. The primers were designed using the Primer Express computer software program (Applied Biosystems) based on the bovine sequences. The primer sequences for each gene are given in Table [1](#T1){ref-type="table"}. Each QPCR reaction (25 μl) contained 1 μl cDNA template, 0.5 μl forward primer (20 μM), 0.5 μl reverse primer (20 μM), 12.5 μl Power SYBR^®^Green PCR Master Mix (Applied Biosystems) and 10.5 μl nuclease-free water. The thermal cycling conditions included one cycle at 50°C for 2 min, one cycle at 95°C for 10 min, and 40 cycles at 95°C for 15 s and 60°C for 1 min. Each cDNA template was analyzed for quantitation in duplicate. QPCR and the resulting relative increase in reporter fluorescent dye emission were monitored in real time using an Mx3000P QPCR system (Stratagene, La Jolla, CA, USA). The relative difference in the initial amount of each mRNA species (or cDNA) was determined by comparing the cycle threshold values. To quantify the mRNA concentrations, standard curves for each gene were generated by serial dilution of the plasmid containing its cDNA. The melting curve for detecting the SYBR Green-based objective amplicon were confirmed because SYBR Green also detects double-stranded DNA including primer dimers, contaminating DNA and PCR products from misannealed primers. Contaminating DNA or primer dimers appear as a peak separate from the desired amplicon peak.

###### 

Details of the primers used for quantitative real-time RT-PCR analysis

  Gene name   GeneBank accession number      Primer    Sequences                           Position
  ----------- ------------------------------ --------- ----------------------------------- -----------
  *AMH*       [NM_173890](NM_173890)         Forward   5\'-ACACCGGCAAGCTCCTCAT-3\'         1647-1665
                                             Reverse   5\'-CACCATGTTTGGGACGTGG-3\'         1714-1696
  *CCL2*      [NM_174006](NM_174006)         Forward   5\'-CGCTCAGCCAGATGCAATTA-3\'        110-129
                                             Reverse   5\'-GCCTCTGCATGGAGATCTTCTT-3\'      186-165
  *CYP19*     [NM_174305](NM_174305)         Forward   5\'-TCCATGGGATTTTCCAGGC-3\'         2050-2068
                                             Reverse   5\'-TGGTGGCTTGTCTTTTCCAAC-3\'       2123-2103
  *FSHR*      [NM_174061](NM_174061)         Forward   5\'-AATCTACCTGCTGCTCATAGCCTC-3\'    1300-1323
                                             Reverse   5\'-TTTGCCAGTCGATGGCATAG-3\'        1376-1357
  *GADD45A*   [NM_001034247](NM_001034247)   Forward   5\'-CCGCATTCATCACAGTGGAA-3\'        592-611
                                             Reverse   5\'-CATCACCGTTCAGGGAGATTAATC-3\'    704-681
  *GPX3*      [NM_174077](NM_174077)         Forward   5\'-GCTTCCCCTGCAACCAATT-3\'         357-375
                                             Reverse   5\'-TCGAACATACTTGAGGGTGGCT-3\'      433-412
  *IGFBP5*    [NM_001105327](NM_001105327)   Forward   5\'-ACTGTGACCGCAAAGGGTTCT-3\'       682-702
                                             Reverse   5\'-TTCATCCCGTACTTGTCCACG-3\'       778-758
  *PlGF*      [NM_173950](NM_173950)         Forward   5\'-TGAATGACTCACTCCCTCCATG-3\'      877-898
                                             Reverse   5\'-GGTCTGTCTTCTTTCTCTCACGTTC-3\'   957-933
  *PLAUR*     [NM_174423](NM_174423)         Forward   5\'-CGCGGCCCTATGAATCAAT-3\'         730-748
                                             Reverse   5\'-CTGATGGTGTAGCTTGGGTTCC-3\'      800-779
  *PLA2G1B*   [NM_174646](NM_174646)         Forward   5\'-GGCCTTCATCTGCAACTGTGA-3\'       358-378
                                             Reverse   5\'-TGTGCTCCTTGTTGTATGGCA-3\'       428-408
  *SCD*       [NM_173959](NM_173959)         Forward   5\'-ATTCCCGACGTGGCTTTTTC-3\'        659-678
                                             Reverse   5\'-TTCTTTGACAGCTGGGTGTTTG-3\'      729-708
  *SELP*      [NM_174183](NM_174183)         Forward   5\'-GTCAAGCAGGGCCACTGACTAT-3\'      1700-1720
                                             Reverse   5\'-TCACTAAGCCTGTTGTACCAGCTG-3\'    203-2182
  *SPP1*      [NM_174187](NM_174187)         Forward   5\'-AGCCCTGAGCAAACAGACGAT-3\'       304-324
                                             Reverse   5\'-GCGTCGTCGGAGTCATTAGAGT-3\'      380-359
  *TIMP1*     [NM_174471](NM_174471)         Forward   5\'-CTATGCTGCTGGTTGTGAGGAAT-3\'     508-530
                                             Reverse   5\'-TGAGTGTCGCTCTGCAGTTTG-3\'       582-562
  *TRB2*      [NM_178317](NM_178317)         Forward   5\'-GACCTCAAGCTTCGGAAATTCA-3\'      525-546
                                             Reverse   5\'-CGTCATCTCCCCGCAGAATAT-3\'       621-601
  *TSP2*      [NM_176872](NM_176872)         Forward   5\'-GGAAAACAAGTCATGGCGGA-3\'        3845-3864
                                             Reverse   5\'-TTGAGAGAAGACAAACAGACCCAG-3\'    3928-3902
  *GAPDH*     [U85042](U85042)               Forward   5\'-ACCCAGAAGACTGTGGATGG-3\'        444-463
                                             Reverse   5\'-CAACAGACACGTTGGGAGTG-3\'        621-602

Experiment 2: localization of characteristic genes identified in experiment 1 in healthy and atretic follicles using in situ hybridization
------------------------------------------------------------------------------------------------------------------------------------------

### Sample collection and storage

Ovaries containing follicles more than 8 mm in diameter were obtained from Japanese Black cows at local slaughterhouse. We used only follicles which have a transparent follicular wall and fluid and did not show any aspect of cystic follicles. Eleven follicles were collected and 200 μl of FF was aspirated from each follicle by a syringe fitted with a 27G needle. The FF was snap-frozen and stored at -30°C until hormone determinations. The follicles were dissected from the ovaries and fixed in 10% formalin, embedded in paraffin wax, and stored at 4°C until *in situ*hybridization.

### Steroid hormone determinations

Concentrations of E~2~and P~4~in the FF samples were determined directly in duplicate using a time-resolved fluoroimmunoasssay (TR-FIA). The TR-FIA for E~2~and P~4~was performed as previously described by our laboratory \[[@B23],[@B24]\]. The FF samples were diluted to 100-, 2000- and 5000-fold for E~2~determination and 25-fold for P~4~determination using charcoal-treated plasma (collected from adult Japanese-Black cows). Ranges of the standard curves were 5-200 pg/ml for E~2~ and 0.33-36 ng/ml for P~4~. The intra- and interassay coefficients of variation were 8.2 and 11.4% for E~2~, and 8.5 and 10.5% for P~4~, respectively.

### In situ hybridization

We classified follicles into two groups based on relative levels of FF concentrations of E~2~and P~4~(E~2~/P~4~≥ 1: healthy; E~2~/P~4~\< 1: atretic). Six representative genes differently expressed between F1 and F2 in experiment 1 were selected for *in situ*hybridyzation: anti-Mullerian hormone (*AMH*), cytochrome P450, family XIX (*CYP19*), growth arrest and DNA-damage-inducible, alpha (*GADD45A*), IGF binding protein 5 (*IGFBP5*), placental growth factor (*PlGF*) and thrombospondin 2 (*TSP2*). In these genes, *CYP19*and *IGFBP5*were selected as markers of healthy or atretic follicles since mRNA expression of *CYP19*and *IGFBP5*were up-regulated in the bovine DF and SF, respectively \[[@B25],[@B26]\].

Digoxigenin (DIG)-labeled antisense and sense cRNA probes were prepared as previously described \[[@B27],[@B28]\]. For hybridization, follicles were sectioned into 7 μm-thick sections. We performed *in situ*hybridization using an automated Ventana HX System Discovery with a RiboMapKit and a BlueMapKit (Roche Diagnostics, Basel, Switzerland) as previously described by our laboratory \[[@B27],[@B28]\]. Briefly, the sections were hybridized with DIG-labeled probes in RiboHybe (Roche Diagnostics) hybridization solution at 65°C (*PlGF*) or 61°C (*AMH, CYP19, GADD45A, IGFBP5*and *TSP2*) for 6 hours, then washed for 3 × 6 min in RiboWash (Roche Diagnostics) at 65°C and fixed in RiboFix (Roche Diagnostics) at 37°C, 10 min. The hybridization signals were detected with a rabbit polyclonal anti-digoxin antibody HRP conjugate (Dako Cytomation, Carpinteria, CA, USA) using an AmpMapKit (Roche Diagnostics). The hybridized slides were observed with a Leica DMRE HC microscope (Leica Microsystems, Wetzlar, Germany) and a Nikon Digital Sight DS-Fi1-L2 (Nikon, Tokyo, Japan).

### Statistical analysis

In experiment 1, the expression ratio of each gene to *GAPDH*mRNA was calculated to adjust for variations in the QPCR reaction. The follicular diameter and the QPCR data in experiment 1 and concentrations of E~2~and P~4~and E~2~/P~4~ratio in FF in experiment 2 were analyzed by Mann-Whitney\'s U test. Results were presented as the mean ± SEM. Statistical significance was considered to be at *P*\< 0.05.

Results
=======

Experiment 1: classification of F1 and F2 and identification of genes by microarray analysis and QPCR analysis
--------------------------------------------------------------------------------------------------------------

Mean diameter of F1 and F2 were 10.7 ± 0.7 and 7.8 ± 0.2 mm, respectively (*P*\< 0.05).

### Hierarchical cluster analysis of microarray data

The expression level of 76 genes was enhanced between at least two follicles by more than 20-fold. Using the microarray data of these 76 genes, we performed a hierarchical cluster analysis and constructed a cluster heat map (Figure [1](#F1){ref-type="fig"}). As can be seen from the dendrogram of the sample axis, clustering analysis distinctly separated the five follicles into two clusters (A and B) based on their microarray expression profiles. Cluster A included two follicles that were both F2, whereas cluster B contained the remaining three follicles that were all F1. Cluster analysis also identified two major clusters in the gene axis. One cluster contained 31 genes that were relatively highly expressed in cluster A, while the other contained 45 genes that were relatively highly expressed in cluster B. The details of highly expressed genes in clusters A and B are listed in Table [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}, respectively.

![**Hierarchical cluster analysis of 76 differentially expressed genes in largest (F1) and second-largest follicles (F2)**. These genes were enhanced between at least two follicles by more than 20-fold. Red scale indicates relative higher expression level and green scale indicates relative lower expression level. The expression levels were transformed to log~2~values. Dendrograms of sample axis (above matrix) and gene axis (to the left of matrix) represent overall similarities in gene expression profiles. Five follicles were classified into two major clusters (A and B). The follicles divided into cluster A were all F2 and the follicles divided into cluster B were all F1. The cluster A was characterized by highly expression of 31 genes, whereas the cluster B was predominately expressed 45 genes.](1477-7827-8-11-1){#F1}

###### 

List of differentially expressed genes in cluster A as compared with cluster B.

  **Accession No**.              Gene symbol   Gene name
  ------------------------------ ------------- -----------------------------------------------------------------------------------------------
  [NM_001101080](NM_001101080)   ADAMTS1       ADAM metallopeptidase with thrombospondin type 1 motif, 1
  [NM_206843](NM_206843)         AGOUTI        AGOUTI protein
  [NM_001098982](NM_001098982)   CCDC80        Coiled-coil domain containing 80
  [NM_174006](NM_174006)         CCL2          Chemokine (C-C motif) ligand 2
  [NM_001008670](NM_001008670)   CRABP2        Cellular retinoic acid binding protein 2
  [NM_174290](NM_174290)         CRYAB         Crystallin, alpha B
  [NM_001034247](NM_001034247)   GADD45A       Growth arrest and DNA-damage-inducible, alpha
  [NM_001077112](NM_001077112)   GSTA3         Glutathione S-transferase, alpha 3
  [NM_001105327](NM_001105327)   IGFBP5        Insulin-like growth factor binding protein 5
  [NM_174357](NM_174357)         IL1RN         Interleukin 1 receptor antagonist
  [NM_001033610](NM_001033610)   KRT8          Keratin 8
  [NM_001001138](NM_001001138)   LOC407171     Fc gamma 2 receptor
  [NM_174384](NM_174384)         LOXL4         Lysyl oxidase-like 4
  [NM_174132](NM_174132)         OLR1          Oxidized low density lipoprotein (lectin-like) receptor 1
  [NM_176855](NM_176855)         OXT           Oxytocin
  [NM_001101883](NM_001101883)   PDK4          Pyruvate dehydrogenase kinase, isozyme 4
  [NM_174141](NM_174141)         PENK          Proenkephalin
  [NM_174423](NM_174423)         PLAUR         Plasminogen activator, urokinase receptor
  [NM_001034681](NM_001034681)   RTKN          Rhotekin
  [NM_174183](NM_174183)         SELP          Selectin P
  [NM_174137](NM_174137)         SERPINE1      Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
  [NM_001075764](NM_001075764)   SFRP4         Secreted frizzled-related protein 4
  [NM_174601](NM_174601)         SLC1A5        Solute carrier family 1 (neutral amino acid transporter), member 5
  [NM_174187](NM_174187)         SPP1          Secreted phosphoprotein 1
  [NM_003254](NM_003254)         TIMP1         TIMP metallopeptidase inhibitor 1
  [NM_176872](NM_176872)         TSP2          Thrombospondin 2
  [AW430112](AW430112)                         Transcription factor B1, mitochondrial
  [BE721140](BE721140)                         Transcribed locus
  [BP101259](BP101259)                         Caldesmon, smooth muscle
  [XM_587930](XM_587930)                       Similar to ATP-binding cassette sub-family G member 1 (ABCG1), mRNA.
  [XM_869699](XM_869699)                       Similar to tumor necrosis factor receptor superfamily, member 12A

###### 

List of differentially expressed genes in cluster B as compared with cluster A.

  **Accession No**.              Gene symbol   Gene name
  ------------------------------ ------------- --------------------------------------------------------------------------------------------------------
  [NM_173890](NM_173890)         AMH           Anti-Mullerian hormone
  [NM_174518](NM_174518)         CITED1        Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1
  [NM_174304](NM_174304)         CYP17         Cytochrome P450, subfamily XVII
  [NM_174305](NM_174305)         CYP19         Cytochrome P450, family XIX, aromatase
  [NM_001034410](NM_001034410)   CXCL14        Chemokine (C-X-C motif) ligand 14
  [NM_182786](NM_182786)         FOS           V-fos FBJ murine osteosarcoma viral oncogene homolog
  [NM_174061](NM_174061)         FSHR          Follicle stimulating hormone receptor
  [NM_175801](NM_175801)         FST           Follistatin
  [NM_001083674](NM_001083674)   GCLC          Glutamate-cysteine ligase, catalytic subunit
  [NM_174077](NM_174077)         GPX3          Glutathione peroxidase 3
  [NM_174546](NM_174546)         GUCA1A        guanylate cyclase activator 1A (retina)
  [NM_001102365](NM_001102365)   HSD17B1       Hydroxysteroid (17-beta) dehydrogenase 1
  [NM_174555](NM_174555)         IGFBP2        Insulin-like growth factor binding protein 2, 36 kDa
  [NM_174094](NM_174094)         INHA          Inhibin, alpha
  [NM_174363](NM_174363)         INHBA         Inhibin, beta A (activin A, activin AB alpha polypeptide)
  [NM_173950](NM_173950)         PlGF          Placental growth factor
  [NM_174646](NM_174646)         PLA2G1B       Phospholipase A2, group IB (pancreas)
  [NM_174753](NM_174753)         PTHLH         Parathyroid hormone-like hormone
  [NM_173957](NM_173957)         RGN           Regucalcin (senescence marker protein-30)
  [NM_173959](NM_173959)         SCD           Stearoyl-CoA desaturase (delta-9-desaturase)
  [NM_174670](NM_174670)         SERPINF2      Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
  [NM_001098036](NM_001098036)   SLC39A14      Solute carrier family 39 (zinc transporter), member 14
  [NM_001025326](NM_001025326)   SRGN          Serglycin
  [NM_001076470](NM_001076470)   TMEM20        Transmembrane protein 20
  [NM_001007813](NM_001007813)   TNFAIP6       Tumor necrosis factor, alpha-induced protein 6
  [NM_178317](NM_178317)         TRB2          TRB-2 protein
  [AW315959](AW315959)                         13940 MARC 4BOV Bos taurus cDNA 5\', mRNA sequence.
  [AW325368](AW325368)                         16365 MARC 4BOV Bos taurus cDNA 5\', mRNA sequence.
  [BE684800](BE684800)                         186519 MARC 4BOV Bos taurus cDNA 5\', mRNA sequence.
  [BI536463](BI536463)                         393463 MARC 4BOV Bos taurus cDNA 5\', mRNA sequence
  [BI536468](BI536468)                         393469 MARC 4BOV Bos taurus cDNA 5\', mRNA sequence.
  [BI537443](BI537443)                         397313 MARC 4BOV Bos taurus cDNA 5\', mRNA sequence.
  [BP102158](BP102158)                         Transcribed locus
  [BP103904](BP103904)                         BP103904 ORCS bovine liver cDNA Bos taurus cDNA clone ORCS25139 3\', mRNA sequence.
  [BP104736](BP104736)                         BP104736 ORCS bovine liver cDNA Bos taurus cDNA clone ORCS26135 3\', mRNA sequence.
  [BP105513](BP105513)                         BP105513 ORCS bovine liver cDNA Bos taurus cDNA clone ORCS27141 3\', mRNA sequence.
  [BP107839](BP107839)                         BP107839 ORCS bovine utero-placenta cDNA Bos taurus cDNA clone ORCS11248 3\', mRNA sequence.
  [BP108716](BP108716)                         Isolate UoG-BovSAGE-UK2 unknown mRNA
  [BP110155](BP110155)                         Testis derived transcript (3 LIM domains)
  [BP110180](BP110180)                         Transcribed locus
  [BP110819](BP110819)                         BP110819 ORCS bovine utero-placenta cDNA Bos taurus cDNA clone ORCS11012 5\', mRNA sequence.
  [BP111150](BP111150)                         BP111150 ORCS bovine utero-placenta cDNA Bos taurus cDNA clone ORCS11443 5\', mRNA sequence.
  [XM_614289](XM_614289)                       Similar to glucocorticoid induced transcript 1 (GLCCI1), mRNA.
  [XM_864694](XM_864694)                       Similar to tolloid-like 2, transcript variant 2 (TLL2), mRNA.

### Quantitative PCR analysis of representative highly expressed genes in F1 and F2

Figure [2](#F2){ref-type="fig"} shows the results of QPCR analysis of the eight representative genes that were highly expressed in F2 (cluster A) compared with F1 (cluster B) in microarray analysis. Messenger RNA expression for chemokine ligand 2 (*CCL2*), *GADD45A*, *IGFBP5*, plasminogen activator urokinase receptor (*PLAUR*), secreted phosphoprotein 1 (*SPP1*), selectin P (*SELP*), tissue inhibitor of matrix metalloprotease-1 (*TIMP1*) and *TSP2*was greater in the F2 than in the F1 (*P*\< 0.05). The results of QPCR analysis of the eight representative genes that were highly expressed in the F1 as compared with the F2 in microarray analysis are shown in Figure [3](#F3){ref-type="fig"}. The expression of *AMH*, *CYP19*, *FSHR*, glutathione peroxidase 3 (*GPX3*), *PlGF*, phospholipase A2 group 1B (*PLA2G1B*), stearoyl-CoA desaturase (*SCD*) and tribbles homolog 2 (*TRB2*) mRNA was greater in the F1 than in the F2 (*P*\< 0.05).

![**QPCR analysis of representative eight genes (*CCL2, GADD45A, IGFBP5, PLAUR, SELP, SPP1, TIMP1*and *TSP2*) in F1 and F2**. These genes were highly expressed in F2 (cluster A) compared with F1 (cluster B) in microarray analysis. The expression of mRNA was normalized to the expression of *GAPDH*measured in the same RNA preparation. The black bar and the white bar indicate the F1 and the F2, respectively. Data are shown as the mean ± SEM. Different letters denote significant differences (*P*\< 0.05).](1477-7827-8-11-2){#F2}

![**QPCR analysis of representative eight genes (*AMH, CYP19, FSHR, GPX3, PlGF, PLA2G1B, SCD*and *TRB2*) in F1 and F2**. These genes were highly expressed in F1 (cluster B) compared with F2 (cluster A) in microarray analysis. The expression of mRNA was normalized to the expression of *GAPDH*measured in the same RNA preparation. The black bar and the white bar indicate the F1 and the F2, respectively. Data are shown as the mean ± SEM. Different letters denote significant differences (*P*\< 0.05).](1477-7827-8-11-3){#F3}

Experiment 2: localization of characteristic genes identified in experiment 1 in healthy and atretic follicles using in situ hybridization
------------------------------------------------------------------------------------------------------------------------------------------

### Follicular fluid concentrations of E~2~and P~4~in follicles

We classified follicles into healthy or atretic based on the relative concentrations of E~2~and P~4~in FF (healthy: E~2~/P~4~ratio ≥1, atretic: E~2~/P~4~ratio \<1). From a total of 11 follicles, eight were categorized into healthy while the other three were atretic. Table [4](#T4){ref-type="table"} shows the characteristics of the follicles used in experiment 2. Healthy follicles had higher E~2~and lower P~4~concentrations in FF than atretic follicles. The E~2~/P~4~ratio in FF was significantly higher in healthy follicles than in atretic follicles.

###### 

Follicular fluid concentrations of estradiol (E~2~) and progesterone (P~4~) in examined follicles used in experiment 2.

  Follicle   E~2~(ng/ml)    P~4~(ng/ml)       E~2~/P~4~ratio
  ---------- -------------- ----------------- ----------------
  Healthy    180.0 ± 44.9   15.9 ± 15.3       4.3 ± 0.8
  Atretic    41.4 ± 5.3\*   387.7 ± 121.7\*   0.1 ± 0.1\*

Values are mean ± SEM

\* *P*\< 0.05 *vs*. healthy follicle

### In situ hybridization of representative genes identified in experiment 1

Figure [4](#F4){ref-type="fig"} shows mRNA localization for *GADD45A*, *IGFBP5*and *TSP2*in healthy and atretic follicles by *in situ*hybridization. These genes were highly expressed in F2 than in F1 in microarray and QPCR analysis of experiment 1. *IGFBP5*mRNA was localized in the GC and theca layer (TL) of atretic follicles but not in healthy follicles (Figure [4E, F, G](#F4){ref-type="fig"} and [4H](#F4){ref-type="fig"}). *GADD45A*(Figure [4A, B, C](#F4){ref-type="fig"} and [4D](#F4){ref-type="fig"}) and *TSP2*(Figure [4I, J, K](#F4){ref-type="fig"} and [4L](#F4){ref-type="fig"}) mRNA were found in both GC and TL of atretic follicles but they were expressed in only GC of healthy follicles. No significant signals were detected with any sense probes (Figure [4B, D, F, H, J](#F4){ref-type="fig"} and [4L](#F4){ref-type="fig"}).

![**Localization of *GADD45A, IGFBP5*and *TSP2*mRNA in healthy and atretic follicles**. These genes were expressed more in F2 than in F1 in QPCR analysis. (A, C, E, G, I and K) DIG-labeled anti-sense cRNA probes were used. (B, D, F, H, J and L) DIG-labeled sense cRNA probes were used. Seven-micrometer sections of bovine follicles were hybridized with each probe. *GADD45A*(A, B, C and D) and *TSP2*(I, J, K and L) mRNA were found in both granulosa cells (GC) and theca layer (TL) of atretic follicle, whereas it was localized in only GC of healthy follicle. *IGFBP5*mRNA (E, F, G and H) was localized in GC and TL of atretic follicle but not found in healthy follicle. Scale bar = 20 μm.](1477-7827-8-11-4){#F4}

Localization of *AMH*, *CYP19*and *PlGF*mRNA in healthy and atretic follicles are shown in Figure [5](#F5){ref-type="fig"}. These genes were expressed more in the F1 than in the F2 in experiment 1. *AMH*(Figure. [5A, B, C](#F5){ref-type="fig"} and [5D](#F5){ref-type="fig"}) and *CYP19*(Figure. [5E, F, G](#F5){ref-type="fig"} and [5H](#F5){ref-type="fig"}) mRNA was localized in GC of healthy as well as atretic follicles. *PlGF*mRNA was found in GC and TL of only healthy follicles but not atretic follicles (Figure. [5I, J, K](#F5){ref-type="fig"} and [5L](#F5){ref-type="fig"}). No significant signals were detected with any sense probes (Figure. [5B, D, F, H, J](#F5){ref-type="fig"} and [5L](#F5){ref-type="fig"}).

![**Localization of *AMH, CYP19*and *PlGF*mRNA in healthy and atretic follicles**. These genes were expressed more in F1 than in F2 in QPCR analysis. (A, C, E, G, I and K) DIG-labeled anti-sense cRNA probes were used. (B, D, F, H, J and L) DIG-labeled sense cRNA probes were used. Seven-micrometer sections of bovine follicles were hybridized with each probe. *AMH*(A, B, C and D) and *CYP19*(E, F, G and H) mRNA was localized in granulosa cells (GC) of healthy as well as atretic follicles. *PlGF*mRNA (I, J, K and L) was found in GC and theca layer of healthy follicle but not atretic follicle. Scale bar = 20 μm.](1477-7827-8-11-5){#F5}

Discussion
==========

In this study, as expected, hierarchical cluster analysis of the microarray data classified F1 and F2 according to differences in gene expression profiles. In each follicular group, characteristic genes determining their developmental status were expressed. The F1 showed greater expression of genes responsible for enhancement of follicular E~2~ production than the F2. These genes were gonadotropin receptor (*FSHR*), steroidogenic enzymes (*CYP17, CYP19*and *HSD17B1*) and inhibin-activin-follistatin system (*INHA*, *INHBA*and *FST*). It is well demonstrated that mRNA expression for *FSHR*, *CYP17*, *CYP19*, *INHA*and *INHBA*increases with the progress of bovine follicular development and is greater in DF than SF \[[@B8],[@B12],[@B29]\]. On the other hand, the F2 had greater expression of *IGFBP5*mRNA than the F1. *IGFBP5*mRNA expression dramatically increased in bovine atretic follicles compared with the DF \[[@B26]\]. Intrafollicular levels of IGFBP proteolytic activity and *IGFBPs*gene expression are important for bioavailability of free IGF within the follicle and play a crucial role for determining follicular dominance and fate \[[@B7],[@B30]\]. Therefore, we evaluated the F1 were selected DF and the F2 were unselected SF.

Our evaluation of follicular status was confirmed to investigate *CYP19*and *IGFBP5*mRNA localization in healthy and atretic follicles in experiment 2 using *in situ*hybridization. *CYP19*mRNA was abundantly expressed in healthy follicles but it was also expressed in atretic follicles while *IGFBP5*mRNA was detected only in atretic follicles. Both *CYP19*and *IGFBP5*mRNA is hormonally regulated in bovine follicular cells \[[@B31]-[@B34]\], in addition, in situ hybridization is not quantitative and not be as sensitive as QPCR. Thus, small amounts of *CYP19*and *IGFBP5*mRNA may be detected or regulated in atretic and healthy follicles, respectively. Since we did not perform sample collection at a specific phase of follicular wave in experiment 1, detailed growth profiles of the follicles we used were unclear. However, our results demonstrate that randomly collected follicles can be divided into several groups by similarities of gene expression profiles among the follicles and suggest that gene expression profiles of examined follicles are closely associated with their development status.

Confirmation of microarray data by QPCR analysis successfully identified a set of genes differentially expressed between the F1 and F2. In addition, possible involvement of these genes in follicular development and/or atresia was further demonstrated to investigate mRNA localization in healthy and atretic follicles. The F1 showed greater expression of genes involved in follicular growth and survivability (*AMH*, *PLA2G1B*, *SCD2*and *TRB2*) than the F2. High expression of these genes may be closely associated with the establishment and maintenance of follicular dominance. Although the functional role of AMH in antral follicle development is poorly understood, recent studies showed that both intrafollicular AMH concentration and *AMH*mRNA expression were highest in small antral follicles and then decreased with follicular growth, suggesting the involvement of AMH in bovine follicular recruitment and/or selection \[[@B16],[@B35],[@B36]\]. A recent study showed a significant decrease of *AMH*mRNA expression in late atretic follicles compared with healthy follicles \[[@B36]\], which is consistent with our present result. Furthermore, in agreement with previous studies \[[@B16],[@B37]\], our *in situ*hybridization study showed that *AMH*mRNA was localized in only GC. High expression and clear localization of *AMH*mRNA in the GC of healthy large follicles implies that this growth factor has a plausible effect on the development of DF after follicular selection as well as recruitment.

PLA2 enzymes including PLA2G1B hydrolyze fatty acids from the sn-2 position of phospholipids with concomitant formation of lysophospholipids, which serve as precursor for lipid mediators such as lysophosphatidic acid (LPA) \[[@B38],[@B39]\]. Released LPA has diverse biological activities including cell proliferation and differentiation, suppression of apoptosis and cytoskeleton modulation in reproductive tissues \[[@B39]\]. Because Diouf *et al*. reported that *PLA2G1B*mRNA expression in the GC of bovine preovulatory follicle decreased after hCG injection \[[@B40]\], PLA2G1B may mainly contribute to generation of LPA during DF growth before the LH surge.

SCD is a rate-limiting enzyme that catalyzes the synthesis of monounsaturated fatty acids, mainly palmitic and oleic acid \[[@B41]\]. Consistent with our result, *SCD*mRNA expression in bovine follicles was found to be highest in GC of DF than in cohort follicles before selection or SF \[[@B11],[@B17]\]. Expression of *SCD2*is hormonally regulated during follicular development because both SCD2 mRNA and protein expression in rat large follicles were stimulated by gonadotropin and IGF-I treatment \[[@B42]\]. Increase of monounsaturated acids synthesize by SCD2 activation during DF growth may be required to maintain membrane fluidity \[[@B43]\] and a major lipid reserve of oocytes \[[@B44]\].

Members of the TRB family including TRB2 interact and modulate the activity of mitogen-activated protein kinase (MAPK) which regulates cell proliferation, differentiation, apoptosis and survival \[[@B45]\]. These MAPK cascade protein levels were greater in DF than in SF \[[@B46]\]. In addition, it has been reported that *TRB2*mRNA was constantly expressed between bovine small follicles and DF \[[@B11]\]. These studies and our present result suggest the potential role of TRB2 in the regulation of MAPK cascades in the growing DF.

The F2 are characterized by high expression of the genes involved in immune reaction (*CCL2*, *SELP*and *SPP1*). In bovine follicles, expression of *CCL2*and *SPP1*mRNAs and SELP protein was up-regulated in association with follicular development and ovulation \[[@B16],[@B18],[@B47]\]. Our results raise the possibility that these immune-related genes may be involved in bovine follicular atresia as well as follicular development and ovulation. Both CCL2 and SELP mediate induction of leukocyte emigration into extravascular inflammatory sites \[[@B48]\]. Although SPP1, also known as osteopontin, has diverse physiological functions, one of its potent actions is recruitment and retention of macrophages and T cells to inflamed sites \[[@B49]\]. Since number of leukocytes, lymphocytes and activated macrophages are increased in atretic follicles \[[@B50]\], CCL2, SELP and SPP1 participate in the regulation of inflammatory processes during follicular atresia to attract white blood cells.

The F2 are also characterized by high expression of genes regulating tissue remodeling (*TIMP1*and *PLAUR*). Both plasminogen activator (PA)-plasmin and matrix metalloproteinase (MMP) systems play a crucial role in the degradation and remodeling of extracellular matrix associated with follicular development, ovulation and atresia \[[@B51]\]. Urokinase PA (uPA) receptor is a specific cell surface receptor for uPA and its principal role is to localize pericellular plasmin activity to induce extracellular matrix degradation \[[@B52]\]. A previous study showed that there was no difference in mRNA expression levels of uPA between non-atretic and atretic bovine follicles, whereas atretic follicles had lower FF protein level and mRNA expression of a PA inhibitor and higher FF plasmin activity than non-atretic follicles \[[@B53]\]. Therefore, the follicular PA-plasmin system may be primarily regulated by changes in their receptors and inhibitors\' expressions. TIMP-1 is an intrinsic inhibitor of MMPs and preferentially binds to MMP-9 \[[@B54]\]. A previous study demonstrated that MMP-9 proenzyme (proMMP-9) protein in FF was detected only in atretic follicles but not in healthy follicles in cattle \[[@B55]\]. Atretic follicles may balance MMPs and TIMP-1 in response to an increase in proMMP-9 to control extracellular matrix degradation by MMP-9.

In the present study, we identified differential expression of two anti-apoptosis factors (*GADD45A*and *GPX3*) between the groups. Expression of *GADD45A*mRNA was greater in the F2 than in the F1. GADD45A controls cell cycle arrest, apoptosis induction and DNA damage repair in response to DNA damaging agents and growth arrest signals of genotoxic stress \[[@B56]\]. Our result implies that the atretic follicles suffered more severe DNA damage than healthy follicles. Indeed, we found in experiment 2 that the atretic follicles expressed *GADD45A*mRNA in both GC and TL whereas the healthy follicles expressed it only in GC. This result supports our microarray result and suggests an increase in the requirement of GADD45A activity for progression of apoptotic cell death in GC and TC during follicular atresia. On the other hand, *GPX3*mRNA was found to be more greatly expressed in the F1 than in the F2. Glutathione peroxidase protects cells against oxidative damage to catalyze the reduction of free hydrogen peroxide and other hydroperoxides \[[@B57]\]. High oxidative stress can trigger apoptosis of follicular cells and induce atresia \[[@B58]\]. In cultured swine GC, *GPX3*mRNA expression was upregulated by FSH treatment \[[@B59]\]. Thus GPX3 could prevent cell apoptosis from oxidative stress during growth of the healthy follicles. It is likely that follicular oxidative stress-response enzymes are expressed in a stage-dependent manner since mRNA expression of other anti-oxidative stress enzymes in bovine GC was increased in atretic DF than in healthy DF \[[@B60]\].

Providing a sufficient blood supply is essential for follicular growth \[[@B61],[@B62]\]. A morphological study has demonstrated that bovine healthy DF has a high density and well developed capillaries in TL whereas atretic follicles has sparse and poorly developed capillaries \[[@B63]\]. In the present study, two genes regulating angiogenesis, *PlGF*and *TSP2*, were differentially expressed between the groups. *PlGF*was expressed most in F1 than in F2 and localized in both GC and TL of healthy follicles but not detected in atretic follicles. PlGF is a member of the vascular endothelial growth factor family and stimulates the proliferation of endothelial cells and supports angiogenesis \[[@B64],[@B65]\]. Therefore, PlGF may contribute to follicular thecal angiogenesis via paracrine/autocrine action in healthy follicles as well as other angiogenic factors. In contrast to PlGF, TSP-2, a member of the TSP family, acts as a potent inhibitor of angiogenesis and induces endothelial cell apoptosis \[[@B66]\]. In experiment 1, *TSP2*mRNA expression was greater in the F2 than in the F1. *TSP2*mRNA level in the bovine follicles decreased in accordance with an increase in follicular diameter \[[@B67]\]. The same authors also showed that TSP protein was localized in both GC and TC of small follicles but in only in the GC of large follicles \[[@B67]\]. We demonstrated in experiment 2 that *TSP2*mRNA was localized in both GC and TL of atretic follicles while it was expressed in only GC of healthy follicles. Recent studies have demonstrated that mRNA and protein expression of TSP-1, another antiangiogenic TSP, is upregulated in primate GC during progression of follicular atresia \[[@B68]\] and *TSP1*mRNA abundance is decreased by IGF-I treatment in cultured porcine GC \[[@B69]\]. Thus, we speculate that *TSP2*mRNA expression is maintained at high levels in follicular cells of atretic follicles whereas it decreases in healthy follicles. Highly expressed *TSP2*mRNA in the follicles could negatively influence their angiogenesis. It may cause an insufficient supply of substrates essential for follicular growth, thereby affecting follicular hormone production and cell proliferation, and, as a result, inducing atresia.

Conclusion
==========

Microarray and QPCR analysis enabled us to classify uncharacterized bovine follicles and to evaluate their representative follicular status according to differences in global gene expression profiles. Our present study demonstrates that the expression of stage-specific genes in F1 and F2 may be closely associated with follicular growth and atresia. Several genes identified in this study will provide information on the genomic actions of intriguing candidates for the determinant of bovine follicular development.
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